Market map
Oncology
The oncology technology landscape is rapidly evolving as precision medicine platforms and early cancer detection tools secure massive funding. High-value data solutions and AI-driven diagnostic tools are shaping the future of cancer care delivery across North America and Europe.
30 companies, 16 sub-segments, from our own research
The desk's read
Cancer screening and diagnostics represents the most crowded sub-segment, led by heavily funded firms like Caris Life Sciences alongside numerous regional diagnostic specialists.
Sub-segments such as clinical trial matching and oncology benefit management remain thin, represented by only a few specialized players like Massive Bio and OncoHealth.
Capital is heavily concentrated in early cancer detection and precision medicine, with market leaders Grail, Tempus, and Freenome collectively commanding billions of dollars.
Buyers should watch the growth of AI-powered radiology and patient companion software, where emerging companies are scaling digital tools to optimize clinical workflows.
Cancer screening and diagnostics
7
Early cancer detection
3
Precision medicine platform
3
Real-world data and analytics
2
Oncology care navigation
2
AI-powered radiology diagnostics
2
Patient companion software
2
AI drug discovery
1
AI digital pathology
1
AI-powered pathology diagnostics
1
Oncology care platform
1
Clinical trial matching
1
Cancer risk assessment
1
Patient empowerment platform
1
Cancer screening
1
Oncology benefit management
1
Our own research, our own segmentation. Browse every Oncology company or open the full database.